By Charles Toutant | March 29, 2024
A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.
By Maria Dinzeo | March 29, 2024
The Department of Justice and Federal Trade Commission are worried that the growing use of algorithms is making price fixing increasingly difficult to detect—and that the use of AI to create ever-more-sophisticated algorithms will exacerbate that challenge.
By Maydeen Merino | March 27, 2024
Antitrust victories in the Third Circuit in the early 2000s likely led the Justice Department to sue in New Jersey federal court.
By Charles Toutant | March 25, 2024
Like the Department of Justice suit, the consumer class actions claim Apple engages in exclusionary conduct to shut competitors out of the markets for revenue from areas such as its App Store, Apple Pay and music streaming.
By Chris O'Malley | March 21, 2024
"We allege that Apple has maintained monopoly power in the smartphone market, not simply by staying ahead of the competition on the merits, but by violating federal antitrust law," Attorney General Merrick Garland said Thursday.
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
By Maria Dinzeo | November 1, 2023
"My main criteria for the future will be to work with fantastic humans and to find yet another challenge that puts my experiences to their best possible use," Stark said in a LinkedIn post.
By Allison Dunn | October 20, 2023
U.S. District Senior Judge Rebecca Beach Smith of the Eastern District of Virginia approved the final settlement agreement between a class of drug purchasers and pharmaceutical companies, Merck & Co., and Glenmark Pharmaceuticals, which also requires the defendants to pay one-third of the settlement fund in attorney fees, or $23 million, as well as $3.9 million in costs—as requested by plaintiffs' counsel.
By Charles Toutant | October 17, 2023
Axon's average prices for a body-worn camera went to $489 in 2022 from $169 in 2017, according to court documents.
By Charles Toutant | August 23, 2023
Room revenue reported to the New Jersey Casino Control Commission has shown substantial increases, even while occupancy rates have fallen and gaming revenues have increased only modestly, the suits claim
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS